Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Little Green Pharma Ltd. ( (AU:LGP) ) just unveiled an update.
Little Green Pharma Ltd announced the results of its Annual General Meeting held on August 21, 2025. Key resolutions, including the adoption of the 2025 remuneration report, were passed, avoiding a ‘second strike’ under the Corporations Act. However, some resolutions, such as the approval of a 10% placement facility, were not carried. The meeting also marked the retirement of Director David Fenlon, leading to the withdrawal of related resolutions. These outcomes reflect the company’s ongoing governance and strategic decisions impacting its market operations and stakeholder relations.
The most recent analyst rating on (AU:LGP) stock is a Buy with a A$0.18 price target. To see the full list of analyst forecasts on Little Green Pharma Ltd. stock, see the AU:LGP Stock Forecast page.
More about Little Green Pharma Ltd.
Little Green Pharma Ltd is a company operating in the pharmaceutical industry, focusing on the production and distribution of medical cannabis products. The company is listed on the Australian Securities Exchange (ASX) and aims to provide innovative health solutions through its cannabis-based offerings.
Average Trading Volume: 133,992
Technical Sentiment Signal: Buy
Current Market Cap: A$35.06M
Learn more about LGP stock on TipRanks’ Stock Analysis page.